A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors
Condition: Malignant Tumor Intervention: Device: Experimental: DaRT seeds Sponsor: Alpha Tau Medical LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
Condition: Glioblastoma Interventions: Radiation: Accelerated Hypofractionated Radiation Therapy; Procedure: Computed Tomography; Drug: Fluorodopa F 18; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Other: Quality-of-Life Assessment; Other: Questionnaire Administratio n; Radiation: Radiation Therapy; Drug: Temozolomide Sponsor: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials
A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors
Condition: Malignant Tumor Intervention: Device: Experimental: DaRT seeds Sponsor: Alpha Tau Medical LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
Condition: Glioblastoma Interventions: Radiation: Accelerated Hypofractionated Radiation Therapy; Procedure: Computed Tomography; Drug: Fluorodopa F 18; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Other: Quality-of-Life Assessment; Other: Questionnaire Administratio n; Radiation: Radiation Therapy; Drug: Temozolomide Sponsor: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Condition: Pancreatic Cancer Intervention: Radiation: Daily Adaptive External Beam Radiation Therapy Sponsors: Varian, a Siemens Healthineers Company; Washington University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2023 Category: Research Source Type: clinical trials
High-dose Rate (HDR) Brachytherapy Boost With Stereostatic Body Radiation Therapy (SBRT) to Intermediate or Higher Risk Prostate Cancer
Condition: Prostatic Cancer Interventions: Radiation: High Dose Brachytherapy; Radiation: Stereostatic Body Radiation Therapy Sponsor: University of Nebraska Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials